Medly Therapeutics
PrivateLast Round
Grant
Feb 18, 2025
Total Funding Raised
$1.35M
Company Overview
Medly Therapeutics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in February 2025.
Medly Therapeutics is a digital health company that provides an AI-powered, clinically validated platform for the remote management of chronic conditions, including heart failure.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Patient Engagement, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medly Therapeutics Comparables
Compare Medly Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeamlessMD | 76% | |
| Veta Health | 76% | |
| CareSimple | 73% |
For institutional investors. Book with your work email.
Medly Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Medly Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
$1.35M grant from Canadian Institutes of Health Research
For institutional investors. Book with your work email.
Medly Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medly Therapeutics's valuation, stock price, and market status.
Is Medly Therapeutics a public or private company?
Medly Therapeutics is a private company.
What is the current stock price of Medly Therapeutics?
Medly Therapeutics is a private company, so its shares have no public market price. Caplight tracks Medly Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medly Therapeutics worth (valuation)?
Valuation information for Medly Therapeutics is not publicly available.
Can I buy Medly Therapeutics stock?
Medly Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medly Therapeutics's last funding round?
Medly Therapeutics's most recent funding round was Grant on February 18, 2025.
Who are the main investors in Medly Therapeutics?
Key investors in Medly Therapeutics include Canadian Institutes of Health Research.
Will Medly Therapeutics IPO soon?
No public IPO plans have been announced for Medly Therapeutics.
How can I track Medly Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Medly Therapeutics's shares on secondary markets.